Citadel Advisors’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
FMI
BIP
TAM
TRSOTSOK
IHAM
Citadel Advisors's FMS Position: Q1 2026 in Review
Citadel Advisors increased its Fresenius Medical Care (FMS) stake by 99% in Q1 2026, buying an estimated $645K and bringing the position to 56,578 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #7123.
Citadel Advisors first reported a position in FMS in Q2 2016 and has held it in 36 quarters since. The position peaked at $16.3M in Q3 2022. 219 funds tracked by Wall St. Rank hold FMS as of Q1 2026.
- Citadel Advisors held 56,578 shares of Fresenius Medical Care worth $1.28M as of Q1 2026.
- Citadel Advisors bought 28,089 Fresenius Medical Care shares in Q1 2026, an estimated $645K.
- Fresenius Medical Care made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7123 holding.
- Citadel Advisors first reported a position in Fresenius Medical Care in Q2 2016 and has held it in 36 quarters since.
- Citadel Advisors's Fresenius Medical Care position peaked at $16.3M in Q3 2022.
- 219 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.